Urologix, Inc.

Equities

ULGX

US9172731047

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 14:48:12 08/03/2024 GMT			5-day change	1st Jan Change
0.0001 ^USD	+9,900.00%		-.--%	-.--%

2016	A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	CI
2015	Urologix Conducting A Strategic Review	CI

Urologix, Inc. Announces Resignation of Ralph P. Cardinal as Vice President, Research and Development

February 16, 2012 at 05:11 pm

Effective February 10, 2012, Ralph P. Cardinal, Vice President, Research and Development of Urologix, Inc. resigned from his position to pursue other opportunities.

Latest news about Urologix, Inc.

A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	01/02/16	CI
Urologix Conducting A Strategic Review	09/07/15	CI
Transcript : Urologix, Inc., Q3 2015 Earnings Call, May 12, 2015	12/05/15
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015	12/05/15	CI
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015	23/03/15	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014	05/02/15	CI
Transcript : Urologix, Inc., Q2 2015 Earnings Call, Feb 05, 2015	05/02/15
Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014	12/01/15	CI
Transcript : Urologix, Inc., Q1 2015 Earnings Call, Nov 04, 2014	04/11/14
Urologix, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2014; Provides Cash Flow Guidance for the Fiscal 2015	04/11/14	CI
Transcript : Urologix, Inc., Q4 2014 Earnings Call, Aug 19, 2014	19/08/14
Urologix, Inc. Announces Executive Changes	19/08/14	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015	19/08/14	CI
Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	28/05/14	CI
Transcript : Urologix, Inc., Q3 2014 Earnings Call, May 06, 2014	06/05/14
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	06/05/14	CI
Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014	10/04/14	CI
Transcript : Urologix, Inc., Q2 2014 Earnings Call, Feb 04, 2014	04/02/14
Urologix Secures Extension of Credit Facility	04/02/14	CI
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2013	04/02/14	CI
Urologix, Inc. Reports Revenue Results for the Second Quarter Ended December 31, 2013; Withdraws Previously Issued Fiscal Year 2014 Revenue Guidance	08/01/14	CI
Transcript : Urologix, Inc., Q1 2014 Earnings Call, Oct 29, 2013	29/10/13
Urologix, Inc. Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2013; Reaffirms Revenue Guidance for Fiscal 2014	29/10/13	CI
Transcript : Urologix, Inc., Q4 2013 Earnings Call, Aug 20, 2013	20/08/13
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2013; Provides Revenue Guidance for the Fiscal Year 2014; Reports Impairment Charges for the Fourth Quarter Ended June 30, 2013	20/08/13	CI

Chart Urologix, Inc.

Duration

Period

More charts

Company Profile

21st North Inc. is not engaged in any operating activity. The Company has dissolved.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
UROLOGIX, INC.	-.--%	2.13K
DANAHER CORPORATION	+8.00%	185B
INTUITIVE SURGICAL, INC.	+31.86%	158B
BOSTON SCIENTIFIC CORPORATION	+33.21%	113B
SIEMENS HEALTHINEERS AG	+2.28%	64.32B
EDWARDS LIFESCIENCES CORPORATION	+21.14%	55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+0.11%	48.41B
AGILENT TECHNOLOGIES, INC.	-6.76%	37.82B
GE HEALTHCARE TECHNOLOGIES INC.	+0.78%	35.57B
RESMED, INC.	+11.28%	28.12B

Other Advanced Medical Equipment & Technology